科恩-斯蒂尔斯金融(CNS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CNS 科恩-斯蒂尔斯金融

盘前交易 05-08 06:29:17 EDT

71.10

+0.56

+0.79%

盘前70.76

-0.34-0.48%

04:02 EDT

最高72.04	最低70.25	成交量25.83万
今开70.91	昨收70.54	日振幅2.54%
总市值36.54亿	流通市值19.61亿	总股本5,139万
成交额1,840万	换手率0.94%	流通股本2,758万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CNS","market":"US","secType":"STK","nameCN":"科恩-斯蒂尔斯金融","latestPrice":71.1,"timestamp":1778184000000,"preClose":70.54,"halted":0,"volume":258302,"hourTrading":{"tag":"盘前","latestPrice":70.76,"preClose":71.1,"latestTime":"04:02 EDT","volume":71,"amount":5029.98009,"timestamp":1778227339738,"change":-0.34,"changeRate":-0.004782,"amplitude":0.001969},"delay":0,"changeRate":0.00793875815140329,"floatShares":27582175,"shares":51390184,"eps":3.020118,"marketStatus":"盘前交易","change":0.56,"latestTime":"05-08 06:29:17 EDT","open":70.91,"high":72.04,"low":70.25,"amount":18401980.705429,"amplitude":0.025376,"askPrice":84.66,"askSize":100,"bidPrice":54.87,"bidSize":100,"shortable":3,"etf":0,"ttmEps":3.020118,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778247000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1092369600000,"exchange":"NYSE","adjPreClose":71.1,"dividendRate":0.035617,"preHourTrading":{"tag":"盘前","latestPrice":70.76,"preClose":71.1,"latestTime":"04:02 EDT","volume":71,"amount":5029.98009,"timestamp":1778227339738,"change":-0.34,"changeRate":-0.004782,"amplitude":0.001969},"postHourTrading":{"tag":"盘后","latestPrice":71.1,"preClose":71.1,"latestTime":"16:10 EDT","volume":5173,"amount":367800.3,"timestamp":1778184605164,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8223551405535285,"impliedVol":0.272,"impliedVolPercentile":0.572},"requestUrl":"/m/hq/s/CNS","defaultTab":"news","newsList":[{"id":"2630356204","title":"都说CNS是个坑，艾伯维偏偏不信邪","url":"https://stock-news.laohu8.com/highlight/detail?id=2630356204","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630356204?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:32","pubTimestamp":1777260779,"startTime":"0","endTime":"0","summary":"然而，艾伯维却是一个例外。凭借CNS领域的强劲表现，艾伯维在2024年成功扭转下滑态势：营收同比增长4%，达到563.34亿美元；2025年更是迎来加速增长，同比增幅达8.6%，营收突破611.6亿美元。CNS业务的重要性，也在这一涨一跌中凸显无遗。02 艾伯维的CNS弹药箱艾伯维CNS的根基，在于2019年的那次关键收购。而Ubrelvy作为全球首款口服CGRP受体拮抗剂，主打急性偏头痛治疗；Qulipta则专注于成人发作性偏头痛和慢性偏头痛的预防，二者形成互补。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1777002450558131291","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4135","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127258539","title":"财报前瞻｜科恩-斯蒂尔斯金融本季度营收预计小幅提升，机构观点偏稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=1127258539","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127258539?lang=zh_cn&edition=full","pubTime":"2026-04-10 08:20","pubTimestamp":1775780457,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融将于2026年04月17日发布新一季度财报，市场聚焦费用率与利润弹性变化对盈利质量的影响。市场一致预期显示，本季度科恩-斯蒂尔斯金融营收预计为1.43亿美元，同比增长9.74%；调整后每股收益预计为0.81美元，同比增长6.58%。由于外部披露中未提供本季度毛利率与净利润或净利率的预测值，上述两项暂不展示。近期围绕科恩-斯蒂尔斯金融的新季度财报，主流机构观点更偏向稳健。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜科恩-斯蒂尔斯金融本季度营收预计小幅提升，机构观点偏稳健","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623930549","title":"上市后首份年报出炉，英硅智能如何以BD走稳商业化？","url":"https://stock-news.laohu8.com/highlight/detail?id=2623930549","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623930549?lang=zh_cn&edition=full","pubTime":"2026-03-31 14:49","pubTimestamp":1774939740,"startTime":"0","endTime":"0","summary":"3月29日，英硅智能公布了港股上市后的首份年报。紧随其后，英硅智能宣布与礼来达成27.5亿美元合作。根据协议，礼来将获得一项全球独家许可，用于开发、生产和商业化针对特定适应症、目前处于临床前开发阶段的、具有潜在“同类最佳”水平的新型口服治疗药物。此外，英硅智能与礼来还将围绕礼来选定的靶点开展多项研发项目合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690313762.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690313762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CNS","VGT","BK4587","BK4551","CHAT","AI","BK4135","AGIX","BK4543","AIPO","BK1191","01477","AIYY","BK4528","BK4588","BK4585","BK4023","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622568885","title":"英硅智能(03696)与元羿生物拓展AI驱动CNS领域研发合作 新合作总金额最高可达9475万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622568885","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622568885?lang=zh_cn&edition=full","pubTime":"2026-03-26 08:03","pubTimestamp":1774483392,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英硅智能 发布公告，在过去一年良好的合作关系基础上，英硅智能与Tenacia Biotechnology  Co., Limited，一家致力于为未被满足的神经系统疾病患者开发创新治疗方案的商业化生物制药公司，已达成一项扩展的AI驱动研发合作。本次拓展合作的总交易金额最高可达9475万美元。英硅智能有望获得元羿生物支付近期款项及里程碑款项等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AGIX","AIPO","BK1141","BK4135","CHAT","03696","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153315660","title":"Reviva制药拟启动公开发行，募资推进精神分裂症三期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1153315660","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153315660?lang=zh_cn&edition=full","pubTime":"2026-03-19 04:13","pubTimestamp":1773864804,"startTime":"0","endTime":"0","summary":"Reviva Pharmaceuticals Holdings, Inc.于2026年3月18日宣布，计划进行公开发行，出售其普通股及认股权证。本次发行全部由公司自身售股，最终完成将取决于市场及其他条件，发行规模与具体条款尚存不确定性。A.G.P./Alliance Global Partners担任此次发行的独家配售代理。公司计划将本次发行净收益连同现有现金及等价物，用于资助研发活动，其中包括brilaroxazine治疗精神分裂症的RECOVER-2三期临床试验，以及营运资本和其他一般企业用途。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RVPH","BK4135","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614031743","title":"Silo Pharma, Inc.盘中异动 早盘急速下跌9.66%报0.315美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614031743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614031743?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:31","pubTimestamp":1772029862,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日22时31分，Silo Pharma, Inc.股票出现波动，股价急速下挫9.66%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223102a4c7a676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223102a4c7a676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","SILO","BK4139","BK4202","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609432256","title":"释放pipeline in a drug潜力 NLRP3能否催生下一个“药王”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2609432256","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609432256?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:35","pubTimestamp":1770280559,"startTime":"0","endTime":"0","summary":"近期，英硅智能(03696)宣布提名靶向NLRP3的外周限制性抑制剂ISM5059，该候选药物具有新颖母核，由英硅智能自有Pharma.AI平台驱动设计。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260205/20260205163220_51027.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260205/20260205163220_51027.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["PD","BBB","BK4135","BK4132","IBD","BK4023","LU1169590202.USD","CNS","LU1169589451.USD","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593682434","title":"Silo Pharma, Inc.盘中异动 股价大涨8.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593682434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593682434?lang=zh_cn&edition=full","pubTime":"2025-12-23 05:00","pubTimestamp":1766437200,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日05时00分，Silo Pharma, Inc.股票出现波动，股价大幅上涨8.51%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223050001a46bc7a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223050001a46bc7a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4202","BK4139","BK4135","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107912016","title":"科恩-斯蒂尔斯金融宣布2026年一、二、三月的分配","url":"https://stock-news.laohu8.com/highlight/detail?id=1107912016","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107912016?lang=zh_cn&edition=full","pubTime":"2025-12-18 05:00","pubTimestamp":1766005211,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融宣布2026年一、二、三月的分配","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4135","UTF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172304311","title":"科恩-斯蒂尔斯金融推出基础设施机会和短期优先证券的主动型ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=1172304311","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172304311?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:48","pubTimestamp":1765378133,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融推出基础设施机会和短期优先证券的主动型ETF","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSIO","CNS","CSSD","CSPF","CSRE","CSNR","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142793926","title":"科恩-斯蒂尔斯金融连续第六年被《养老金与投资》评选为“最佳资产管理工作场所”","url":"https://stock-news.laohu8.com/highlight/detail?id=1142793926","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142793926?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:30","pubTimestamp":1765200627,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融连续第六年被《养老金与投资》评选为“最佳资产管理工作场所”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586474490","title":"2025年，药企已达成4起超百亿元收购！","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474490","media":"制药网","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586474490?lang=zh_cn&edition=full","pubTime":"2025-11-25 10:28","pubTimestamp":1764037735,"startTime":"0","endTime":"0","summary":"2025年，全球药企收购活动频发。其中，多家跨国巨头围绕弥补核心产品增长短板、补强细分赛道管线等原因，已展开了多笔超百亿元人民币的收购。默沙东92亿美元收购Cidara Therapeutics11月17日消息，默沙东宣布以92亿美元现金收购Cidara Therapeutics，将其处于3期临床试验的主要资产流感预防药物CD388收入囊中。2024年6月，该药已获美国FDA批准上市，作为维持疗法治疗COPD成人患者。据悉，其此次收购旨在进一步扩大强生在实体瘤及前列腺癌治疗领域的业务版图。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112510331395189b86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112510331395189b86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4581","LU0070217475.USD","LU0912757837.SGD","LU2129689514.USD","LU0466842654.USD","LU0234570918.USD","IE00BGHQF631.EUR","LU0320765646.SGD","LU1032466523.USD","LU2129689431.USD","IE00BFXG1179.USD","LU1261432733.SGD","LU0289739699.SGD","LU0345770308.USD","SG9999002224.SGD","BK4007","JNJ","LU1280957306.USD","LU0345769128.USD","LU0234572021.USD","LU1061106388.HKD","LU0889566641.SGD","IE00B2B36J28.USD","BK4585","LU1066051498.USD","LU0795875086.SGD","LU2430703178.SGD","LU1674673691.USD","IE00BVYPNV92.GBP","LU1430594728.SGD","LU1585245621.USD","SG9999002232.USD","IE00BZ1G4Q59.USD","IE00BN8TJ469.HKD","LU1244550494.USD","LU2430703095.HKD","LU0058720904.USD","CNS","BK4532","LU1059921491.USD","LU2592432038.USD","BK4135","IE00B3T34201.USD","IE00B19Z3581.USD","LU1074936037.SGD","LU0985320562.USD","IE00B7SZLL34.SGD","IE00BBT3K403.USD","LU1935042991.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586747554","title":"Silo Pharma, Inc.盘中异动 急速上涨5.05%报0.410美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586747554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586747554?lang=zh_cn&edition=full","pubTime":"2025-11-25 02:10","pubTimestamp":1764007827,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日02时10分，Silo Pharma, Inc.股票出现异动，股价大幅拉升5.05%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125021028a4b79ba4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125021028a4b79ba4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4202","SILO","BK4135","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583163687","title":"Silo Pharma, Inc.盘中异动 股价大涨5.67%报0.460美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583163687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583163687?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:39","pubTimestamp":1763131199,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日22时39分，Silo Pharma, Inc.股票出现异动，股价急速拉升5.67%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114224000976996ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114224000976996ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","SILO","BK4139","BK4202","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517118521","title":"科恩-斯蒂尔斯金融盘中异动 大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517118521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517118521?lang=zh_cn&edition=full","pubTime":"2025-03-07 04:51","pubTimestamp":1741294269,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日04时51分，科恩-斯蒂尔斯金融股票出现波动，股价快速拉升5.04%。科恩-斯蒂尔斯金融股票所在的资产管理行业中，整体跌幅为1.87%。科恩-斯蒂尔斯金融公司简介：科恩-斯蒂尔斯金融有限公司是一家专注于房地产证券的利基资产管理公司。科恩-斯蒂尔斯金融有限公司还管理专门的投资组合 优先证券、公用事业股票和其他高收益产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307045109abebd343&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307045109abebd343&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","CNS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2516580686","title":"Silo Pharma, Inc.盘中异动 股价大跌5.46%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516580686?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:52","pubTimestamp":1741017146,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时52分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.46%。截至发稿，该股报1.28美元/股，成交量2.1069万股，换手率0.47%，振幅4.43%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235227989a244e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235227989a244e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4202","BK4135","BK4139","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514438101","title":"Silo Pharma, Inc.盘中异动 股价大跌5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514438101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514438101?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:44","pubTimestamp":1740671073,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时44分，Silo Pharma, Inc.股票出现异动，股价大幅跳水5.67%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234433abdf8164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227234433abdf8164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4202","BK4139","BK4135","CNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514086930","title":"Silo Pharma, Inc.盘中异动 快速上涨5.40%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086930","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514086930?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:30","pubTimestamp":1740594617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时30分，Silo Pharma, Inc.股票出现波动，股价急速拉升5.40%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702301896317b61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022702301896317b61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4135","BK4139","CNS","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514604186","title":"Silo Pharma, Inc.盘中异动 急速拉升5.56%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514604186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514604186?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:58","pubTimestamp":1740517098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时58分，Silo Pharma, Inc.股票出现异动，股价急速拉升5.56%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260458189892928d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260458189892928d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","SILO","CNS","BK4135","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727576","title":"Silo Pharma, Inc.盘中异动 早盘股价大跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727576?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:48","pubTimestamp":1740408534,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时48分，Silo Pharma, Inc.股票出现异动，股价急速下跌5.19%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242248549890fa1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242248549890fa1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SILO","BK4139","BK4135","CNS","BK4202"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cohenandsteers.com","stockEarnings":[{"period":"1week","weight":0.0115},{"period":"1month","weight":0.1322},{"period":"3month","weight":0.1338},{"period":"6month","weight":0.038},{"period":"1year","weight":-0.0847},{"period":"ytd","weight":0.1325}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.1098},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.3037},{"period":"ytd","weight":0.0728}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cohen & Steers, Inc.于2004年3月17日组建为特拉华州的公司。该公司是一家专注于实物资产和另类收入的全球投资管理公司，专注于上市和私人房地产、优先证券、基础设施、资源股票和大宗商品。该公司总部位于纽约市，通过在主要金融中心的办事处为全球机构和个人投资者提供服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.017702},{"month":2,"riseRate":0.5,"avgChangeRate":-0.001473},{"month":3,"riseRate":0.681818,"avgChangeRate":0.022621},{"month":4,"riseRate":0.681818,"avgChangeRate":0.055792},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.002456},{"month":6,"riseRate":0.571429,"avgChangeRate":-0.003319},{"month":7,"riseRate":0.619048,"avgChangeRate":0.029905},{"month":8,"riseRate":0.52381,"avgChangeRate":0.008352},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.011439},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.004744},{"month":11,"riseRate":0.636364,"avgChangeRate":0.008954},{"month":12,"riseRate":0.5,"avgChangeRate":0.016009}],"exchange":"NYSE","name":"科恩-斯蒂尔斯金融","nameEN":"Cohen & Steers"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科恩-斯蒂尔斯金融(CNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科恩-斯蒂尔斯金融(CNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科恩-斯蒂尔斯金融,CNS,科恩-斯蒂尔斯金融股票,科恩-斯蒂尔斯金融股票老虎,科恩-斯蒂尔斯金融股票老虎国际,科恩-斯蒂尔斯金融行情,科恩-斯蒂尔斯金融股票行情,科恩-斯蒂尔斯金融股价,科恩-斯蒂尔斯金融股市,科恩-斯蒂尔斯金融股票价格,科恩-斯蒂尔斯金融股票交易,科恩-斯蒂尔斯金融股票购买,科恩-斯蒂尔斯金融股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科恩-斯蒂尔斯金融(CNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科恩-斯蒂尔斯金融(CNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}